Large-scale testing (Phase 3)Study completedNCT01294215What this trial is testingHigh Dose BAYA1040_Nifedipine: a Long Term Combination StudyWho this might be right forHypertension Bayer 72
Not applicableActive Not RecruitingNCT05017935What this trial is testingRADIANCE Continued Access ProtocolWho this might be right forHypertensionHypertension, Resistant to Conventional TherapyVascular Diseases+1 more ReCor Medical, Inc. 300
Large-scale testing (Phase 3)Study completedNCT00751751What this trial is testingOlmesartan Medoxomil Versus Losartan in Elderly and Very ElderlyWho this might be right forEssential Hypertension Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 441
Testing effectiveness (Phase 2)Looking for participantsNCT06826872What this trial is testingEfficacy and Safety of SPC1001 in Patients With Essential HypertensionWho this might be right forHypertension, EssentialCardiovascular DiseasesCardiology Shin Poong Pharmaceutical Co. Ltd. 252
Large-scale testing (Phase 3)Study completedNCT02072330What this trial is testingStudy to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.Who this might be right forGrade I or II Essential Hypertension Takeda 353
Large-scale testing (Phase 3)Study completedNCT04927299What this trial is testingEfficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial HypertensionWho this might be right forEssential Arterial Hypertension Laboratorios Silanes S.A. de C.V. 163
Not applicableLooking for participantsNCT07051811What this trial is testingTo Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary HypertensionWho this might be right forEssential Hypertension Lepu Medical Technology (Beijing) Co., Ltd. 213
Large-scale testing (Phase 3)Study completedNCT01756430What this trial is testingEfficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential HypertensionWho this might be right forHypertension Chong Kun Dang Pharmaceutical 238
Testing effectiveness (Phase 2)Study completedNCT00277875What this trial is testingSTRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISHWho this might be right forCardiovascular Disease Synvista Therapeutics, Inc 25
Large-scale testing (Phase 3)WithdrawnNCT02047019What this trial is testingMonotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWho this might be right forHypertension Bayer
Large-scale testing (Phase 3)Study completedNCT00236665What this trial is testingEfficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionWho this might be right forObesityHypertension Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531
Large-scale testing (Phase 3)Study completedNCT06121518What this trial is testingClinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 MonotherapyWho this might be right forEssential Hypertension Chong Kun Dang Pharmaceutical 235
Very early researchUnknownNCT05103813What this trial is testingProtective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMIWho this might be right forEssential Hypertension Shenzhen People's Hospital 100
Not applicableStudy completedNCT01562613What this trial is testingA Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With EprosartanWho this might be right forHypertensionStroke Abbott 533
Testing effectiveness (Phase 2)Study completedNCT00288184What this trial is testingUric Acid in Essential Hypertension in ChildrenWho this might be right forEssential Hypertension National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Early research (Phase 1)Study completedNCT00923533What this trial is testingEvaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 34
Testing effectiveness (Phase 2)Study completedNCT02603809What this trial is testingDose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential HypertensionWho this might be right forEssential Hypertension Idorsia Pharmaceuticals Ltd. 1,659
Large-scale testing (Phase 3)Study completedNCT00706134What this trial is testingEfficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled StudyWho this might be right forHypertension Novartis 756
Testing effectiveness (Phase 2)Ended earlyNCT00802893What this trial is testingOral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial DysfunctionWho this might be right forIsolated Systolic HypertensionEndothelial Dysfunction Johns Hopkins University 3
Testing effectiveness (Phase 2)Study completedNCT04218552What this trial is testingDetermining the Optimal Dose of AD-209 in Patients With Essential HypertensionWho this might be right forHypertension,Essential Addpharma Inc. 176